Amir Avraham
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amir Avraham
Amir Avraham is recorded as CEO at Revium Rx. (RVRC). Revium Rx. reported in an 8-K filed April 20, 2026 that Amir Avraham was appointed permanent Chief Executive Officer, effective February 1, 2026.
“On April 14, 2026, the Board of Directors of Revium Rx (“we,” “us,” “our,” “Revium” or the “company”) appointed Mr. Amir Avraham, who has served as the Company’s interim Chief Executive Officer, to serve as the permanent Chief Executive Officer of the Company and of its subsidiaries, effective as of February 1, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Revium Rx.
Other people whose current roles at this company are on record from its filings.
- Shlomi Schwartzblat Chairman, Board Member
- Igor Bluvstein CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.